Recordati reported EUR189.59M in Selling and Administration Expenses for its fiscal quarter ending in September of 2026.





Selling And Administration Expenses Change Date
Almirall -29.5M 4.72M Jun/2026
GlaxoSmithKline GBP 2.16B 39M Sep/2026
Hikma Pharmaceutical USD 288M 149M Dec/2025
Orion EUR 98.9M 0 Sep/2026
Sanofi EUR 2.31B 325M Sep/2026